CIOS: Critical Illness Outcomes Study

Sponsor
National Institute of General Medical Sciences (NIGMS) (NIH)
Overall Status
Unknown status
CT.gov ID
NCT01109719
Collaborator
(none)
6,000
1
9
666.5

Study Details

Study Description

Brief Summary

We will test whether the way that an intensive care unit is organized can influence patient related outcomes such as mortality. We will test whether who works in the ICU, and how the ICU is managed will affect the care received by patients. The primary study hypothesis is whether the number of clinical protocols present in an intensive care unit is linked to patient mortality

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Title: Do ICU Structural and Procedural Factors Influence Patient Related Outcomes: The Critical Illness Outcome Study (CIOS)

    Objectives: This is an exploratory ecologic study designed to examine the organizational and structural factors present in adult intensive care units in the United States. A second objective is to determine whether these organizational and structural factors are associated with patient related outcomes. In addition, we intend to examine whether these organizational and structural issues are associated with patient treatments.

    Hypotheses: (Ho) A. The number of protocols used in an ICU is inversely associated with ICU and hospital survival for critically ill patients.

    1. Compliance with disease specific protocols is not independently associated with hospital survival for critically ill patients

    Specific Aims

    1. To describe the organizational structure of participating intensive care units

    2. To determine whether the number of protocols used in an intensive care unit is associated with ICU and hospital survival for critically ill patients

    3. To determine the frequency with which ICU's follow disease specific protocols for patients with sepsis and ALI

    Study Design

    1. Prospective ecologic study of 50-60 adult intensive care units and admitted patients

    2. ICU organizational and structural data will be collected for each participating ICU

    3. 125-200 adult patients in each intensive care unit will be enrolled. Patients within the ICU on a varying, specific day each week will be included. Demographic and treatment variables will be collected for that day on that patient. Outcome data will be collected on ICU and hospital discharge.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    6000 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    The Association of ICU Organization and Structure on in Patient Mortality
    Study Start Date :
    Jul 1, 2010
    Anticipated Primary Completion Date :
    Feb 1, 2011
    Anticipated Study Completion Date :
    Apr 1, 2011

    Outcome Measures

    Primary Outcome Measures

    1. In Patient Mortality [Hospital discharge or 60 days]

    Secondary Outcome Measures

    1. 2. Mortality prior to ICU discharge 3. Length of ICU stay 4. Length of hospital stay ICU mortality [ICU discharge or 60 days]

    2. ICU length of stay [ICU discharge or 60 days]

    3. Length of hospital stay [Hospital discharge or 60 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Hospitalized adult patient in a study ICU on the date of data collection. This includes patients who may be in ICU despite not having critical illness for reasons such as lack of floor beds.
    Exclusion Criteria:
    1. Patient enrolled on previous study collection day 2 Previous enrollment into other study ICU 3. Age < 18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Johns Hopkins Bayview Medical Center Baltimore Maryland United States 21224

    Sponsors and Collaborators

    • National Institute of General Medical Sciences (NIGMS)

    Investigators

    • Principal Investigator: Jonathan Sevransky, MD, MHS, Johns Hopkins University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01109719
    Other Study ID Numbers:
    • CIITG-2
    • K23GM071399
    First Posted:
    Apr 23, 2010
    Last Update Posted:
    Aug 25, 2010
    Last Verified:
    Aug 1, 2010
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 25, 2010